Derek Dixon Ascends to Chief Information Security Officer at Fresenius Kabi

Fresenius Kabi, a global frontrunner in the healthcare sector, specializing in lifesaving medicines and technologies, has promoted Derek Dixon to the position of Chief Information Security Officer (CISO). Dixon, a seasoned professional with a rich history at Fresenius Kabi, has dedicated over a decade of service to the company, previously excelling as the Vice President of Engineering. This promotion marks a significant milestone in his career, as he now takes on the mantle from Dan Nathan, a revered figure who has significantly contributed to shaping the company’s technical landscape for 17 years. Nathan will continue his association with Fresenius Kabi as a Senior Engineering Advisor.

Dixon’s journey with Fresenius Kabi has been marked by notable achievements and responsibilities. Before ascending to the role of CISO, he led as the Senior Director of Cybersecurity, where he was instrumental in steering the cybersecurity direction for the Fresenius Kabi organization. His tenure saw him as a key member of the Fresenius Group security committee, ensuring compliance with data security standards through technological and physical access controls. Dixon has been at the forefront of developing and implementing comprehensive security programs, managing cyber threat analyses, and overseeing all security audits mandated by customers and government agencies.

Prior to his impactful tenure in cybersecurity, Dixon served as the Director of Enterprise Architecture at Fresenius Kabi. Here, he was responsible for aligning global standards with business practices across infrastructure, applications, and service management, fostering synergies within the Fresenius organizations. His initial years at the company were spent managing networks for Fenwal, Inc., a Fresenius Kabi Company, where he led significant projects including the construction of a state-of-the-art data center and the integration of cutting-edge security technologies.

About Fresenius Kabi:

Fresenius Kabi is a behemoth in the healthcare industry, offering a comprehensive portfolio that spans biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generics. The company stands committed to its purpose, “Advancing Patient Care,” by ensuring that critical and chronically ill patients have access to essential medicines and technologies. Through its “Vision 2026” strategy, part of the #FutureFresenius program, Fresenius Kabi is dedicated to enhancing efficiencies in patient therapy and care, improving global access to high-quality healthcare, and aspiring to global leadership in its product segments.

Read more like this Sara Iserman Taylor Embarks on a New Journey as Chief Operating Officer at Texicare